Merck's rotavirus vaccine approved by FDA

02/4/2006 | San Francisco Chronicle

The FDA approved Merck's RotaTeq vaccine against rotavirus, a virus that affects most young children and often is fatal in developing countries. In response to problems with an earlier vaccine, Merck and competitor GlaxoSmithKline conducted trials to ensure their vaccines do not cause dangerous obstructions of the intestine.

View Full Article in:

San Francisco Chronicle

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN